While most primary TNBCs exhibit substantial responses to pre-operative chemotherapy, a failure to achieve complete elimination of viable tumor cells in the breast (so-called pathologic complete response) is associated with very poor outcomes in TNBC but not in ER+ breast cancers9,10. This evidence concerns the gene ESR1 and neoplasm.